1-7 of 7
Vagner O Duarte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Katia B. Pagnano, MD, PhD, Bruna Vergilio, Eliana C M Miranda, MEd, Marcia Torresan Delamain, MD, Maria Helena De Almeida, RN, Vagner O Duarte, Gislaine O. Duarte, PhD, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4941.
https://doi.org/10.1182/blood.V122.21.4941.4941
Published: 2013
Journal Articles

Evaluation Of hOCT1expression In Patients With Chronic Myeloid Leukemia (CML) Treated With Imatinib In First Line

Cintia Do Couto Mascarenhas, PhD, Maria Helena Almeida, PhD, Eliana C M Miranda, MEd, Bruna Virgilio, Marcia Torresan Delamain, MD, Gislaine O. Duarte, PhD, Vagner O Duarte, Carmino A De Souza, Sr., MD, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4041.
https://doi.org/10.1182/blood.V122.21.4041.4041
Published: 2013
Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1326.
https://doi.org/10.1182/blood.V122.21.1326.1326
Published: 2013
Journal Articles

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Beatriz F Ribeiro, Eliana C M Miranda, MEd, Marcia T Delamain, MD, Gislaine Borba Oliveira, MD,, Maria Helena Almeida, RN, Vagner O Duarte, Irene L Metze, MD, PhD, Carmino A De Souza, Sr., MD, PhD, Rosana A Silveira, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5189.
https://doi.org/10.1182/blood.V122.21.5189.5189
Published: 2013
Journal Articles

EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience

Katia B. Pagnano, MD, Irene Lorand-Metze, MD, PhD, Eliana C M Miranda, Vagner O Duarte, Marcia T Delamain, MD, Gislaine O Duarte, MD, Carmino Antonio De Souza, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1681.
https://doi.org/10.1182/blood.V120.21.1681.1681
Published: 2012
Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Katia B. Pagnano, MD, Israel Bendit, MD, Carla Boquimpani, Carmino Antonio De Souza, MD, PhD, Eliana C M Miranda, Rosana A Silveira, Vaneuza A M Funke, MD, Ricardo Pasquini, MD, Vania Hungria, MD, Nelma Clementino, MD, Monika Conchon, Elena B Moiraghi, MD, Jose L. Lopez, MD, Carolina Pavlovsky, MD, Eduardo Cervera, Belinda Pinto Simoes, MD, PhD, Luis A Meillon, MD, Nelson Spector, MD, PhD, Nelson Hamerschlak, MD, Miguel Pavlovsky, Alicia Magarinos, MD, Vagner O Duarte, Ernesto M Fanilla, Jorge E. Cortes, Raquel Bengió, MD
Journal: Blood
Blood (2011) 118 (21): 1701.
https://doi.org/10.1182/blood.V118.21.1701.1701
Published: 2011
Journal Articles

Impact of Imatinib Dose Escalation in Chronic Myeloid Leukemia Patients in Chronic Phase with Sub-Optimal Response or Failure with Imatinib 400 Mg.

Katia BB Pagnano, MD, PhD, Marcia T Delamain, MD, Eliana C.M. Miranda, M.Ed, Vagner O Duarte, Brunna Eulálio Alves, MD, Carmino Antonio De Souza, MD, PhD, Irene Lorand-Metze, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3289.
https://doi.org/10.1182/blood.V114.22.3289.3289
Published: 2009